期刊文献+

维持性血液透析患者住院率及生存率分析 被引量:9

The Analysis of Hospitalization and Survival Rates in Hemodialysis Patients
下载PDF
导出
摘要 目的:了解我中心维持性血液透析(MHD)患者的住院率、死亡率及其原因,为提高患者生存率提供依据。方法:回顾性分析2010年5月~2013年5月我中心MHD患者的住院率、死亡率及其原因,以及治疗前后各项指标的变化。结果:我中心年住院率为595住院次/1 000病人年,主要原因有心脑血管事件(13.0%)、血管通路问题(11.5%)、感染(9.9%)等。死亡率为13人/1 000病人年,主要死亡原因为心脑血管事件(50%)、感染(25%)等。经治疗后所有患者KT/V、Hb、血清钙水平较治疗前均有明显升高(P〈0.05)。结论:心脑血管事件、血管通路、感染是我中心MHD患者住院的主要因素,其中心脑血管事件和感染是死亡的主要原因。 Objective:To observe the hospitalization and survival rates in Hemodialysis patients in the East Department of Sichuan Provincial People's Hospital,and to improve the quality of hemodialysis,to increased the survival.Methods:Retrospective analysis the hospitalization and survival rates and related causes between 2012.3 and 2013.5 in our hemodialysis center,analysis the change before and after treatment.Results:The annual hospitalization rate is 595/1 000 patient-years,the main reason were:cardiovascular and cerebrovascular events(13.0%) 、vascular access problems(11.5%) 、infection(9.9%).The mortality rate was13/1 000 patient-years,the main cause was cardiovascular and cerebrovascular events(50%) 、infection(25%),The KT/V,Hb,Ca were all increased after treatment.Conclusion:Ascular access problems、cardiovascular and cerebrovascular events、infection were the main reason of hospitalization,while cardiovascular and cerebrovascular events、infection were the most reason of death.
出处 《中国中西医结合肾病杂志》 2013年第10期884-886,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 四川省卫生厅科研项目(No.120067 120068)
关键词 维持性血液透析 住院率 死亡率 Hemodialysis Hospitalization rate Mortality rate
  • 相关文献

参考文献8

  • 1Zhang L,Wang F,Wang L,et al.Prevalence of chronic kidney disease in china:a cross-sectional survey.Lancet,2012,379(9818):815-822. 被引量:1
  • 2Go AS,Chertow GM,Fan D,et al.Chronic kidney disease and the risks of death,cardiovascularevents,and hospitalization.N Engl J Med,2004,351(13):1296-305. 被引量:1
  • 3Daratha KB,Short RA,Corbett CF,et al.Risks of subsequent hospitalization and death in patients with kidney disease.Clin J Am Soc Nephrol,2012,7(3):409-416. 被引量:1
  • 4Collins AJ,Foley RN,Charers B,et al.United States Renal Data system,2011 Annual Data Report:atlas of chronic kidney disease and end-stage renal disease in the united states.Am J Kidney Dis,2012 Jan;59(1 Suppl 1):A7,e1-420.doi:10.1053/j.ajkd.2011.11.015. 被引量:1
  • 5蒲蕾,洪大情,何强,邓菲,吴姝焜,王芳,李贵森,王莉.维持性血液透析患者住院及死亡事件分析[J].中国血液净化,2013,12(2):107-109. 被引量:17
  • 6付瑶,常明,刘书馨.老年维持性血液透析尿毒症患者死亡原因及相关因素分析[J].中国中西医结合肾病杂志,2009,10(1):58-60. 被引量:25
  • 7Cheung AK,Sarnak MJ,Yan G,et al.Cardiac diseases in maintenance hemodialysis patients:results of the HEMO Study.Kidney Int,2004,65(6):2380-2389. 被引量:1
  • 8Vanholder R,Ringoir S,Dhondt A,et al.Phagocy tosis in uremic and hemodialysis patients:a prospective and cross sectional study.Kidney Int,1991,39(2):320-327. 被引量:1

二级参考文献30

  • 1张伟明,钱家麒.上海市透析登记及其结果分析[J].中国血液净化,2012,11(5):233-236. 被引量:83
  • 2常明,刘红,刘书馨,腾兰波,王志宏,刘焱,赵华,付瑶,王伟.尿毒症患者血管钙化及相关因素的研究[J].中华肾脏病杂志,2006,22(9):578-579. 被引量:18
  • 3Qureshi AR, Alvestrand A, Divino - Filho JC, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol, 2002,13 (Suppl 1 ) : S26 -S28. 被引量:1
  • 4Diepeveen SH, Wetzels JF, Bilo HJ, et al. Cholesterol in end - stage renal disease:the good, the bad or the ugly? Neth J Med, 2008,66(2) :53 - 61. 被引量:1
  • 5Baigent C, Landray MJ, Wheeler BC. Misleading associations between cholesterol and vascular outcomes in dialysis patients: the need for randomized trials. Semin Dial, 2007,20(6) : 498 - 503. 被引量:1
  • 6Cordtz J,Ladefoged SD. Cardiovascular risk factors in hemodialysis patients - reverse epidemiology. Ugeskr Laeger, 2007, 169 (33) :2609 - 2613. 被引量:1
  • 7Xue TL, Ma TL, Louis TA, et al. Forecast of the number of patient with end stage renal disease in the United States to the year 2010. J Am Soc Nephrol,2001,12(12).2753- 2758. 被引量:1
  • 8Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32(5 Suppl 3):S112 - S119. 被引量:1
  • 9Go AS,Chertow GM,Fan D. Chronic kidney disease and the risks of death,cardiovascular events,and hospitalization[J].New England Journal of Medicine,2004.1296-1305. 被引量:1
  • 10Daratha KB,Short RA,Corbett CF. Risks of subsequent hospitalization and death in patients with kidney disease[J].Clin J Am Soc Nephrol,2012.409-416. 被引量:1

共引文献40

同被引文献58

  • 1刘莎,刘文虎.血液透析用水对透析质量的影响[J].中国全科医学,2008,11(19):1802-1804. 被引量:10
  • 2徐静,左力.透析中低血压对患者预后的影响[J].中国血液净化,2012,11(1):46-48. 被引量:22
  • 3王爱平,冯茂玲.血液透析患者自我管理行为问卷的开发[J].中国卫生统计,2005,22(6):368-372. 被引量:98
  • 4Kawanishi H,Akiba T, Masakane I, et al. Standard on microbiological management of fluids for hemodialysis and related therapies by the Japanese Society for Dialysis Therapy 2008 [ J ]. Ther Apher Dial, 2009,13(2): 161-166. 被引量:1
  • 5Boudville N, Homer M, McEwan E, et al. Effect of FX dialysers on systemic inflammation and quality of life in chronic haemodialysis patients [ J ]. Blood Purif, 2009,27 ( 2 ) : 187-193. 被引量:1
  • 6Meuwese CL, Stenvinkel P, Dekker FW, et al. Monitoring of inflammation in patients on dialysis:forewarned is forearmed [J ]. Nat Rev Nephrol, 2011,7 ( 3 ) : 166-176. 被引量:1
  • 7Afizono K, Nomura K, Motoyama T, et al. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis[J]. Blood Purif, 2004,22 Suppl 2 : $26-29. 被引量:1
  • 8Susantitaphong P, Riella C, Jaber BL. Effect of ultrapure dialysate on markers of inflammation, oxidative stress, nutrition and anemia parameters : a meta-analysis [J].Nephrol Dial Transplant, 2013,28 ( 2 ) : 438-446. 被引量:1
  • 9Sehiffl H,Lang SM. Effects of dialysis purity on uremic dyslipidemia[ J ]. Ther hpher Dial,2010,14( 1 ) :5-11. 被引量:1
  • 10Tao J, Sun Y, Li X, et al. Conventional versus ultrapure dialysate for lowering serum lipoprotein (a) levels in patients on long-term hemodialysis:a randomized trial [J]. Int J Artif Organs,2010,33 (5) :290-296. 被引量:1

引证文献9

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部